Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 dose-response study evaluating NCX 470 versus latanoprost in open-angle glaucoma or ocular hypertension has completed with results p…
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos. [Phase 4]
Phase 4 trial update comparing preserved vs preservative-free latanoprost 0.005% in primary open-angle glaucoma and ocular hypertension pati…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. [Phase 3]
Phase 3 bioequivalence study with clinical endpoint comparing bimatoprost ophthalmic solution 0.01% to LUMIGAN in chronic open-angle glaucom…
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension [Phase 1, Phase 2]
A safety, tolerability, and efficacy study (Phase 1/2) of FM101 in patients with ocular hypertension is ongoing, with status currently unkno…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Study of LL-BMT1 in Patients With Elevated Intraocular Pressure [Phase 2]
Phase 2 clinical trial of LL-BMT1 in patients with elevated intraocular pressure has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT [Phase 4]
Phase 4 clinical trial update comparing latanoprost preserved vs unpreserved on tear film thickness measured by OCT in glaucoma and ocular h…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration. [Phase 4]
Phase 4 trial assessing 24-hour efficacy and tolerability of tafluprost-timolol fixed combination without preservatives in glaucomatous or o…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl [Phase 4]
A Phase 4 study evaluating switching from prostaglandin monotherapy to omidenepag isopropyl for prostaglandin-associated peri-orbitopathy in…
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing Bimatoprost SR to selective laser trabeculoplasty in open-angle glaucoma or ocular hypertension has completed with r…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Evaluation of Safety and Efficacy of PDP-716 [Phase 3]
Phase 3 clinical trial evaluating PDP-716 for open angle glaucoma and ocular hypertension has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) ophthalmic solution to GANFORT in open-angle glaucoma and ocular hyper…
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT [Phase 3]
Phase 3 trial evaluating safety and efficacy of OTX-TP in open angle glaucoma and ocular hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial update on efficacy and safety of bimatoprost sustained-release (SR) in open-angle glaucoma and ocular hypertension; results po…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial update for PHP-201 evaluating efficacy and safety in primary open angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt [Phase 3]
A Phase 3 therapeutic equivalence trial comparing generic brinzolamide to Azopt in glaucoma and ocular hypertension has completed with resul…
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt [Phase 1, Phase 2]
A phase 1/2 trial comparing generic brinzolamide to Azopt for glaucoma-related indications has completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 [Phase 2]
Phase 2 clinical trial evaluating 24-hour intraocular pressure lowering and systemic exposure of PF-04217329 in glaucoma and ocular hyperten…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. [Phase 2]
Phase 2 clinical trial updating safety and efficacy of PF-04217329 in patients with primary open-angle glaucoma or ocular hypertension; resu…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients [Phase 3]
Phase 3 trial evaluating latanoprost, timolol, and their combination for eye pressure reduction in open-angle glaucoma and ocular hypertensi…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma [Phase 3]
A Phase 3 randomized, double-masked trial comparing evening dosing of Xalacom in glaucoma and ocular hypertension; the study is completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh. [Phase 4]
Phase 4 trial evaluating the intraocular pressure lowering effect of Xalacom in patients with primary open-angle glaucoma or ocular hyperten…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension [Phase 3]
Phase 3 trial update for Xalacom and a fixed unfixed combination of latanoprost and timolol in open-angle glaucoma or ocular hypertension; t…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A Study of Glaucoma or Ocular Hypertension in Patients Within the United States [Phase 3]
Phase 3 clinical trial update for glaucoma or ocular hypertension sponsored by Pfizer/Mylan (Viatris) has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma [Phase 3]
A Phase 3 randomized trial comparing evening dosing of Xalacom in glaucoma patients has completed, evaluating efficacy and safety in open-an…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure [Phase 3]
Phase 3 trial investigating predictive factors for an additional 10% reduction of intra-ocular pressure in glaucoma and ocular hypertension …